Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21197272 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Sequential Vaccinations in Prostate Cancer Patients
Condition: Prostatic Neoplasms
Interventions: Drug: Recombinant Fowlpox-GM-CSF;   Drug: Recombinant Fowlpox-PSA (L155)-TRICOM (PROSTVAC-F/TRICOM);   Drug: Recombinant Vaccinia-PSA (L155)-TRICOM (PROSTVAC-V/TRICOM);   Drug: Recombinant Human GM-CSF

Indicates status has not been verified in more than two years